Answers are grounded in this paper and cite their sources.
Cefpirome, cefoperazone and ceftazidime were tested for their in-vitro activity against Enterococcus faecalis and methicillin-resistant Staphylococcus aureus (MRSA) isolates. Cefpirome was the most active cephalosporin followed by cefoperazone. Ceftazidime had only very limited activity against these strains. In experiments with cefpirome/vancomycin and cefoperazone/vancomycin combinations, synergy was detected against most MRSA strains and some enterococci. Antagonism did not occur.
No takes yet. Share an insight, caveat, or question.
Seibert et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: